... lymphoblastic leukemia Long non-coding RNA Prognosis Acute lymphoblastic leukemia (ALL) is the most common pediatric malignant neoplasm [ 1 ]. Childhood ALL is a heterogeneous disease, comprising multiple subtypes with distinct cytogenetic and molecular alterations [ 2 ]. The overall cure rates...

.... This single-center retrospective study evaluated clinical and radiological characteristics, treatment modalities, and long-term prognosis of pulmonary MALT lymphoma. Methods: The study included 42 patients diagnosed with pulmonary MALT lymphoma between October 2004 and July 2019. Primary therapeutic...

...Xin He; Yongfang Jiang; Xingbao Yu; Fei He; Haiyan Gao Introduction: The aim of the study was to construct a pyroptosis-related risk score (RS) model for the prognosis of acute myeloid leukemia (AML). Methods: The TARGET (training) and E-MTAB-1216 (validation) datasets were downloaded. Pyroptosis...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Programmed cell death Immune checkpoint Peripheral T-cell lymphoma Prognosis Immune checkpoint pathways play a critical role in immune system regulation, balancing...

...-treatment plasma EBV-DNA concentrations with treatment outcomes and prognosis in patients with PTCL. Methods: We retrospectively reviewed 128 patients diagnosed with PTCL with available data on pre-treatment plasma EBV-DNA, including 63 patients for whom post-treatment plasma EBV-DNA data were also...

...Jinkun Wu; Shupeima Ma; Lingling Sun; Zhiqiang Qin; Zheng Wang; Ning Wang; Mei Lin Background: Angiogenesis in non-Hodgkin lymphoma (NHL) has been investigated by a variety of studies. However, the correlation between angiogenesis and the occurrence or prognosis of NHL patients remains...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Acute myeloid leukemia Flow cytometry Immunophenotype Mutations Prognosis In acute myeloid leukemia (AML), increasing knowledge...

... patients with a worse prognosis within overlapping risk-groups by the prognostic index for PTCL. Conclusions: Our study showed that thrombocytopenia at diagnosis was an independent prognostic factor for survival in patients with PTCL. jeongok77@gmail.com 11 06 2018 8 11 2018 27 2...

... cohort from The Cancer Genome Atlas (TCGA, n = 142). Results: Kaplan-Meier survival analysis revealed that TMEM18 overexpression was associated with a better AML prognosis with good discrimination ( p = 0.019). Interestingly, this ability to predict the prognosis was significant in male AML patients...

... of death when compared to patients with a WHO type of AML-NOS. Conclusion: Our findings highlight the divergent outcomes of patients with AML and the importance of using the WHO classification system and demographic factors to gauge their prognosis. lanjp@163.com 1 06 2017 10 12 2017...

... was found to be mainly unfit for the acute promyelocytic leukemia group. Forty-six patients (17.7%) had elevated fibrinogen levels (>4 g/L) and tended to have a poor prognosis, and thus we redetermined the cutoff value of fibrinogen (<1 g/L or >4 g/L was defined as abnormal). As a result, all...

...Yun Liang; Jie Gao; Dan Wu; Shu Li; Hang Chen; Luyin Ding; Jiefeng Tong; Yang Xu Multiple nonleukemic myeloid sarcoma (MS) is a rare form of MS that is developed in multiple anatomic sites other than bone marrow at diagnosis, without a preceding myeloid neoplasm. The prevalence, prognosis...

... 1.401-3.213) were independent inferior prognostic factors. Conclusions: IDH1 mutation is associated with a poor prognosis. 16 11 2016 17 07 2017 6 09 2017 © 2017 S. Karger AG, Basel Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication...

... suggesting that acute myeloid leukemia patients with high expression levels of WT1 mRNA have a relatively poor long-term survival, there are few reports addressing the relationship between WT1 levels and prognosis in MDS. Methods: We retrospectively analyzed 42 elderly patients with MDS whose WT1 levels...

..., instructions or products referred to in the content or advertisements. 2016 Light-chain amyloidosis Prognosis Treatment Recognition Diagnosis Amyloidosis is a generic idiom for heterogeneous protein misfolding syndromes in which a culprit protein assembles in a β-sheet structure, resulting...

...Aijun Liu; Guangzhong Yang; Chuanying Geng; Huijuan Wang; Lihong Li; Yanchen Li; Yin Wu; Ying Tian; Yun Leng; Guorong Wang; Wen Gao; Wenming Chen To analyze the effects of bortezomib on the prognosis of the newly diagnosed multiple myeloma patients with renal impairment, we assessed the outcomes...

... to in the content or advertisements. Disease-free survival Hodgkin’s lymphoma Immunohistochemistry Overall survival Preferentially expressed antigen of melanoma Prognosis Real-time polymerase chain reaction Hodgkin's lymphoma (HL) is a heterogeneous tumor that develops from germinal center...

... energy metabolism. Multiple myeloma (MM) is an indolent but eventually fatal neoplasm of plasma cells. Autophagy may play a critical role in the survival of MM cells and their response to chemotherapeutic agents. In this study, we correlated the expression of autophagy-related proteins with the prognosis...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Allogeneic hematopoietic cell transplantation Chemotherapy Myelodysplastic syndrome Prognosis Secondary acute myeloid leukemia Secondary acute myeloid leukemia (s...

... analyzed with respect to their influence on prognosis. Results: A total of 132 AML patients were included. Median age was 32 years. Complete remission (CR) was achieved by 55% of patients. CR was achieved by 65.1% of patients <60 years (n = 109), compared to 8.7% of those >60 years (n = 23; p...